A detailed history of New Edge Advisors, LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 168 shares of AVNS stock, worth $2,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares
168
Previous 168 -0.0%
Holding current value
$2,691
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$17.97 - $22.68 $143 - $181
-8 Reduced 4.55%
168 $3,000
Q4 2023

Feb 13, 2024

BUY
$17.64 - $22.99 $529 - $689
30 Added 20.55%
176 $3,000
Q1 2023

May 12, 2023

SELL
$26.92 - $31.75 $242 - $285
-9 Reduced 5.81%
146 $4,000
Q4 2022

Feb 14, 2023

BUY
$19.88 - $27.37 $3,081 - $4,242
155 New
155 $4,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.